With the analysis among 1,158 patents, we discovered top 143 key players by total patent application. Chugai Pharmaceutical Co., Ltd., Pieris Pharmaceuticals GmbH, Genmab A/S are dominant in this area. They take 22.71% of the total patent filing.
Tokyo-to, Japan
Patent: 110
Hovedstaden, Denmark
Patent: 69
Rheinland-Pfalz, Germany
Patent: 59
Cambridgeshire, United Kingdom
Patent: 52
Indiana, United States
Patent: 47
Massachusetts, United States
Patent: 33
With the analysis among 75 patents, we discovered top 6 start-ups by total patent application. Compass Therapeutics LLC, OriCell Therapeutics Co.,Ltd., Systimmune, Inc. are active in this area.
Massachusetts, United States
Patent: 33
Washington, United States
Patent: 9
California, United States
Patent: 7
Shanghai Shi, China
Patent: 4
California, United States
Patent: 2
With the analysis among related 849 patents applied in the last 5 years. We discover 124 most active companies in this area. The fast-growing Chugai Pharmaceutical Co., Ltd., BicycleTx Ltd., Genmab A/S take 25.09% of patent filing during this period.
Tokyo-to, Japan
Patent: 109
Cambridgeshire, United Kingdom
Patent: 52
Hovedstaden, Denmark
Patent: 52
Rheinland-Pfalz, Germany
Patent: 50
Indiana, United States
Patent: 47
Massachusetts, United States
Patent: 33
Shanghai Shi, China
Patent: 28
Jiangsu Sheng, China
Patent: 25
With the analysis among related 849 patents in last 5 years, we discover 80 new entrants. BicycleTx Ltd., Eli Lilly & Co., Compass Therapeutics LLC are the most active new entrants in this area.
Cambridgeshire, United Kingdom
Patent: 52
Indiana, United States
Patent: 47
Massachusetts, United States
Patent: 33
Shanghai Shi, China
Patent: 28
Cambridgeshire, United Kingdom
Patent: 24
ZURICH, Switzerland
Patent: 22
Cambridgeshire, United Kingdom
Patent: 22
Rheinland-Pfalz, Germany
Patent: 17
With the analysis among 95 patents, we discovered top 18 universities and scientific research institutions by total patent application. National University of Singapore, Fondazione Irccs Istituto Nazionale Dei Tumori, Charité - Universitätsmedizin Berlin are dominant in this area. They take 41.05% of the total patent filing.
Central Region, Singapore
Patent: 5
Ohio, United States
Patent: 4
New York, United States
Patent: 2
Guangxi Zhuangzu Zizhiqu, China
Patent: 2
Queensland, Australia
Patent: 1
Shandong Sheng, China
Patent: 1